Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia Glucagon’s effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly wanes. It is not known whether this is also the case under hypoglycemic conditions, where an increase in HGP is essential. This question was addressed using adrenalectomized dogs to avoid the confounding effects of other counterregulatory hormones. During the study, infusions of epinephrine and cortisol were given to maintain basal levels. Somatostatin and insulin (800 µU·kg−1·min−1) were infused to induce hypoglycemia. After 30 min, glucagon was infused at a basal rate (1 ng·kg−1·min−1, baGGN group, n = 5 dogs) or a rate eightfold basal (8 ng·kg−1·min−1, hiGGN group, n = 5 dogs) for 4 h. Glucose was infused to match the arterial glucose levels between groups (≈50 mg/dL). Our data showed that glucagon has a biphasic effect on the liver despite hypoglycemia. Hyperglucagonemia stimulated a rapid, transient peak in HGP (4-fold basal production) over ~60 min, which was followed by a slow reduction in HGP to a rate 1.5-fold basal. During the last 2 h of the experiment, hiGGN stimulated glucose production at a rate fivefold greater than baGGN (2.5 vs. 0.5 mg·kg−1·min−1, respectively), indicating a sustained effect of the hormone. Of note, the hypoglycemia-induced rises in norepinephrine and glycerol were smaller in hiGGN compared with the baGGN group despite identical hypoglycemia. This finding suggests that there is reciprocity between glucagon and the sympathetic nervous system such that when glucagon is increased, the sympathetic nervous response to hypoglycemia is downregulated. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Endocrinology and Metabolism The American Physiological Society

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia

Download PDF
12 pages

Loading next page...
 
/lp/the-american-physiological-society/the-kinetics-of-glucagon-action-on-the-liver-during-insulin-induced-0qKeHDB10w

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0193-1849
eISSN
1522-1555
DOI
10.1152/ajpendo.00466.2019
Publisher site
See Article on Publisher Site

Abstract

Glucagon’s effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly wanes. It is not known whether this is also the case under hypoglycemic conditions, where an increase in HGP is essential. This question was addressed using adrenalectomized dogs to avoid the confounding effects of other counterregulatory hormones. During the study, infusions of epinephrine and cortisol were given to maintain basal levels. Somatostatin and insulin (800 µU·kg−1·min−1) were infused to induce hypoglycemia. After 30 min, glucagon was infused at a basal rate (1 ng·kg−1·min−1, baGGN group, n = 5 dogs) or a rate eightfold basal (8 ng·kg−1·min−1, hiGGN group, n = 5 dogs) for 4 h. Glucose was infused to match the arterial glucose levels between groups (≈50 mg/dL). Our data showed that glucagon has a biphasic effect on the liver despite hypoglycemia. Hyperglucagonemia stimulated a rapid, transient peak in HGP (4-fold basal production) over ~60 min, which was followed by a slow reduction in HGP to a rate 1.5-fold basal. During the last 2 h of the experiment, hiGGN stimulated glucose production at a rate fivefold greater than baGGN (2.5 vs. 0.5 mg·kg−1·min−1, respectively), indicating a sustained effect of the hormone. Of note, the hypoglycemia-induced rises in norepinephrine and glycerol were smaller in hiGGN compared with the baGGN group despite identical hypoglycemia. This finding suggests that there is reciprocity between glucagon and the sympathetic nervous system such that when glucagon is increased, the sympathetic nervous response to hypoglycemia is downregulated.

Journal

AJP - Endocrinology and Metabolism – The American Physiological Society

Published: May 1, 2020

References

  • Glucagon action in the brain
    Abraham, MA; Lam, TK
  • Effect of centrally administered glucagon on blood glucose levels in dogs
    Agarwala, GC; Bapat, SK
  • Glucokinase and molecular aspects of liver glycogen metabolism
    Agius, L
  • Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man
    Bomboy, JD; Lewis, SB; Lacy, WW; Sinclair-Smith, BC; Liljenquist, JE
  • Hormonal control of hepatic glutaminase
    Brosnan, JT; Ewart, HS; Squires, SA
  • Glucagon lowers glycemia when β-cells are active
    Capozzi, ME; Wait, JB; Koech, J; Gordon, AN; Coch, RW; Svendsen, B; Finan, B; D’Alessio, DA; Campbell, JE
  • Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo
    Cherrington, AD
  • Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog
    Cherrington, AD; Diamond, MP; Green, DR; Williams, PE
  • Effect of glucagon on glucose production during insulin deficiency in the dog
    Cherrington, AD; Lacy, WW; Chiasson, JL
  • Differential time course of glucagon’s effect on glycogenolysis and gluconeogenesis in the conscious dog
    Cherrington, AD; Williams, PE; Shulman, GI; Lacy, WW
  • Comparison of the direct and indirect effects of epinephrine on hepatic glucose production
    Chu, CA; Sindelar, DK; Neal, DW; Allen, EJ; Donahue, EP; Cherrington, AD
  • Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis
    Chu, CA; Sindelar, DK; Neal, DW; Cherrington, AD
  • Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog
    Connolly, CC; Adkins-Marshall, BA; Neal, DW; Pugh, W; Jaspan, JB; Cherrington, AD
  • Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog
    Connolly, CC; Ivy, RE; Adkins-Marshall, BA; Dobbins, RL; Neal, DW; Williams, PE; Cherrington, AD
  • Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs
    Connolly, CC; Steiner, KE; Stevenson, RW; Neal, DW; Williams, PE; Alberti, KG; Cherrington, AD
  • The barrier of hypoglycemia in diabetes
    Cryer, PE
  • Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes
    Cryer, PE
  • Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs
    Dobbins, RL; Connolly, CC; Neal, DW; Palladino, LJ; Parlow, AF; Cherrington, AD
  • Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog
    Dobbins, RL; Davis, SN; Neal, DW; Cobelli, C; Cherrington, AD
  • Compartmental modeling of glucagon kinetics in the conscious dog
    Dobbins, RL; Davis, SN; Neal, DW; Cobelli, C; Jaspan, J; Cherrington, AD
  • Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression
    Dunphy, JL; Taylor, RG; Fuller, PJ
  • Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism
    Edgerton, DS; Cardin, S; Emshwiller, M; Neal, D; Chandramouli, V; Schumann, WC; Landau, BR; Rossetti, L; Cherrington, AD
  • Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog
    Edgerton, DS; Cardin, S; Pan, C; Neal, D; Farmer, B; Converse, M; Cherrington, AD
  • Glucagon’s yin and yang effects on hepatic glucose production
    Edgerton, DS; Cherrington, AD
  • Effect of brain glucagon action on hepatic glucose production
    Edgerton, DS; Kraft, G; Farmer, B; Smith, MS; Cherrington, AD
  • Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia
    Eigler, N; Saccà, L; Sherwin, RS
  • Hormonal regulation of amino acid transport in isolated rat hepatocytes: properties of a high affinity transport component induced by glucagon and cyclic AMP
    Fehlmann, M; Freychet, P
  • Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man
    Felig, P; Wahren, J; Hendler, R
  • The role of glucagon in the control of protein and amino acid metabolism in vivo
    Flakoll, PJ; Borel, MJ; Wentzel, LS; Williams, PE; Lacy, DB; Abumrad, NN
  • Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect
    Gerich, JE; Langlois, M; Noacco, C; Karam, JH; Forsham, PH
  • Regulation of urea synthesis by glucose and glucagon in normal man
    Hamberg, O; Vilstrup, H
  • Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes
    Kilberg, MS; Barber, EF; Handlogten, ME
  • Glucagon’s effect on liver protein metabolism in vivo
    Kraft, G; Coate, KC; Winnick, JJ; Dardevet, D; Donahue, EP; Cherrington, AD; Williams, PE; Moore, MC
  • Hormonal regulation of hepatic glucose production in health and disease
    Lin, HV; Accili, D
  • Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate
    Lloyd, B; Burrin, J; Smythe, P; Alberti, KG
  • A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models
    Mari, A; Stojanovska, L; Proietto, J; Thorburn, AW
  • Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat
    Marubashi, S; Tominaga, M; Katagiri, T; Yamatani, K; Yawata, Y; Hara, M; Sasaki, H
  • Hypothalamic glucagon signaling inhibits hepatic glucose production
    Mighiu, PI; Yue, JT; Filippi, BM; Abraham, MA; Chari, M; Lam, CK; Yang, CS; Christian, NR; Charron, MJ; Lam, TKT
  • Targeting hepatic glutaminase activity to ameliorate hyperglycemia
    Miller, RA; Shi, Y; Lu, W; Pirman, DA; Jatkar, A; Blatnik, M; Wu, H; Cárdenas, C; Wan, M; Foskett, JK; Park, JO; Zhang, Y; Holland, WL; Rabinowitz, JD; Birnbaum, MJ
  • Metabolic role of the exercise-induced increment in epinephrine in the dog
    Moates, JM; Lacy, DB; Goldstein, RE; Cherrington, AD; Wasserman, DH
  • Sources of carbon for hepatic glycogen synthesis in the conscious dog
    Moore, MC; Cherrington, AD; Cline, G; Pagliassotti, MJ; Jones, EM; Neal, DW; Badet, C; Shulman, GI
  • Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats
    Morgan, CR; Lazarow, A
  • Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
    Peters, TM; Haidar, A
  • Physiologic action of glucagon on liver glucose metabolism
    Ramnanan, CJ; Edgerton, DS; Kraft, G; Cherrington, AD
  • Low carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: a randomized cross-over study
    Ranjan, A; Schmidt, S; Damm-Frydenberg, C; Steineck, I; Clausen, TR; Holst, JJ; Madsbad, S; Nørgaard, K
  • Glutamine or glutamate release by the liver constitutes a major mechanism for nitrogen salvage
    Rémésy, C; Moundras, C; Morand, C; Demigné, C
  • Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs
    Rivera, N; Ramnanan, CJ; An, Z; Farmer, T; Smith, M; Farmer, B; Irimia, JM; Snead, W; Lautz, M; Roach, PJ; Cherrington, AD
  • Differential effects of epinephrine on glucose production and disposal in man
    Rizza, R; Haymond, M; Cryer, P; Gerich, J
  • Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined α- and β-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia
    Rizza, RA; Cryer, PE; Gerich, JE
  • Glucagon-like substance in the canine brain
    Sasaki, H; Ebitani, I; Tominaga, M; Yamatani, K; Yawata, Y; Hara, M
  • A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog
    Sindelar, DK; Balcom, JH; Chu, CA; Neal, DW; Cherrington, AD
  • Basal hepatic glucose production is regulated by the portal vein insulin concentration
    Sindelar, DK; Chu, CA; Venson, P; Donahue, EP; Neal, DW; Cherrington, AD
  • Whole blood analysis of gluconeogenic amino acids for estimation of de novo gluconeogenesis using pre-column o-phthalaldehyde derivatization and high-performance liquid chromatography
    Venkatakrishnan, A; Abel, MJ; Campbell, RA; Donahue, EP; Uselton, TC; Flakoll, PJ
  • Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs
    Wada, M; Connolly, CC; Tarumi, C; Neal, DW; Cherrington, AD
  • Glutamine and glutamate metabolism across the liver sinusoid
    Watford, M
  • Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis
    Winnick, JJ; Kraft, G; Gregory, JM; Edgerton, DS; Williams, P; Hajizadeh, IA; Kamal, MZ; Smith, M; Farmer, B; Scott, M; Neal, D; Donahue, EP; Allen, E; Cherrington, AD
  • Intra-islet glucagon signaling is critical for maintaining glucose homeostasis
    Zhu, L; Dattaroy, D; Pham, J; Wang, L; Barella, LF; Cui, Y; Wilkins, KJ; Roth, BL; Hochgeschwender, U; Matschinsky, FM; Kaestner, KH; Doliba, NM; Wess, J